請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/6001
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 江福田(Fu-Tien Chiang),蔡佳醍(Chia-Ti Tsai) | |
dc.contributor.author | Cho-Kai Wu | en |
dc.contributor.author | 吳卓鍇 | zh_TW |
dc.date.accessioned | 2021-05-16T16:19:16Z | - |
dc.date.available | 2014-02-25 | |
dc.date.available | 2021-05-16T16:19:16Z | - |
dc.date.copyright | 2014-02-25 | |
dc.date.issued | 2013 | |
dc.date.submitted | 2013-11-25 | |
dc.identifier.citation | (1998). 'How to diagnose diastolic heart failure. European Study Group on Diastolic Heart Failure.' Eur Heart J 19(7): 990-1003.
Abe, T., Y. Ohga, et al. (2002). 'Left ventricular diastolic dysfunction in type 2 diabetes mellitus model rats.' Am J Physiol Heart Circ Physiol 282(1): H138-148. Adams, H. R., C. R. Baxter, et al. (1982). 'Contractile function of heart muscle from burned guinea pigs.' Circ Shock 9(1): 63-73. Ammar, K. A., M. M. Redfield, et al. (2008). 'Central obesity: association with left ventricular dysfunction and mortality in the community.' Am Heart J 156(5): 975-981. Angeja, B. G. and W. Grossman (2003). 'Evaluation and management of diastolic heart failure.' Circulation 107(5): 659-663. Asahi, M., H. Nakayama, et al. (2003). 'Regulation of sarco(endo)plasmic reticulum Ca2+ adenosine triphosphatase by phospholamban and sarcolipin: implication for cardiac hypertrophy and failure.' Trends Cardiovasc Med 13(4): 152-157. Bajraktari, G., M. Berbatovci-Ukimeraj, et al. (2009). 'Predictors of increased left ventricular filling pressure in dialysis patients with preserved left ventricular ejection fraction.' Croat Med J 50(6): 543-549. Baker, D. L., K. Hashimoto, et al. (1998). 'Targeted overexpression of the sarcoplasmic reticulum Ca2+-ATPase increases cardiac contractility in transgenic mouse hearts.' Circ Res 83(12): 1205-1214. Ballard-Croft, C., D. L. Maass, et al. (2002). 'Activation of stress-responsive pathways by the sympathetic nervous system in burn trauma.' Shock 18(1): 38-45. Basu, R., G. Y. Oudit, et al. (2009). 'Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function.' Am J Physiol Heart Circ Physiol 297(6): H2096-2108. Baxter, C. R. and T. Shires (1968). 'Physiological response to crystalloid resuscitation of severe burns.' Ann N Y Acad Sci 150(3): 874-894. Benjamin, I. J. (2012). 'Targeting endoglin, an auxiliary transforming growth factor beta coreceptor, to prevent fibrosis and heart failure.' Circulation 125(22): 2689-2691. Berg, T. J., O. Snorgaard, et al. (1999). 'Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes.' Diabetes Care 22(7): 1186-1190. Bers, D. M. (2008). 'Calcium cycling and signaling in cardiac myocytes.' Annu Rev Physiol 70: 23-49. Bhupathy, P., G. J. Babu, et al. (2007). 'Sarcolipin and phospholamban as regulators of cardiac sarcoplasmic reticulum Ca2+ ATPase.' J Mol Cell Cardiol 42(5): 903-911. Blom, I. E., R. Goldschmeding, et al. (2002). 'Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy?' Matrix Biol 21(6): 473-482. Boltzen, U., A. Eisenreich, et al. (2012). 'Alternatively spliced tissue factor and full-length tissue factor protect cardiomyocytes against TNF-alpha-induced apoptosis.' J Mol Cell Cardiol 52(5): 1056-1065. Borbely, A., I. Falcao-Pires, et al. (2009). 'Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium.' Circ Res 104(6): 780-786. Bryant, D., L. Becker, et al. (1998). 'Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha.' Circulation 97(14): 1375-1381. Budagov, R. S. and L. P. Ul'ianova (2004). '[Role of interleukin-6 (IL-6) in the pathogenesis of combined radiation/thermal injuries].' Radiats Biol Radioecol 44(4): 398-402. Carr, A. N., A. G. Schmidt, et al. (2002). 'Type 1 phosphatase, a negative regulator of cardiac function.' Mol Cell Biol 22(12): 4124-4135. Chrysohoou, C., C. Pitsavos, et al. (2009). 'Chronic systemic inflammation accompanies impaired ventricular diastolic function, detected by Doppler imaging, in patients with newly diagnosed systolic heart failure (Hellenic Heart Failure Study).' Heart Vessels 24(1): 22-26. Chuva de Sousa Lopes, S. M., A. Feijen, et al. (2004). 'Connective tissue growth factor expression and Smad signaling during mouse heart development and myocardial infarction.' Dev Dyn 231(3): 542-550. Claycomb, W. C., N. A. Lanson, Jr., et al. (1998). 'HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte.' Proc Natl Acad Sci U S A 95(6): 2979-2984. Cowie, M. R., A. Mosterd, et al. (1997). 'The epidemiology of heart failure.' Eur Heart J 18(2): 208-225. Davis, B. R., J. B. Kostis, et al. (2008). 'Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.' Circulation 118(22): 2259-2267. de Boer, R. A., D. J. Lok, et al. (2011). 'Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction.' Ann Med 43(1): 60-68. Del Monte, F. and R. J. Hajjar (2008). 'Intracellular devastation in heart failure.' Heart Fail Rev 13(2): 151-162. Deswal, A., N. J. Petersen, et al. (2001). 'Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).' Circulation 103(16): 2055-2059. Dickstein, K., A. Cohen-Solal, et al. (2008). 'ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).' Eur Heart J 29(19): 2388-2442. Dinh, W., R. Futh, et al. (2009). 'Elevated plasma levels of TNF-alpha and interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders.' Cardiovasc Diabetol 8: 58. Duisters, R. F., A. J. Tijsen, et al. (2009). 'miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling.' Circ Res 104(2): 170-178, 176p following 178. Eckel, R. H., S. M. Grundy, et al. (2005). 'The metabolic syndrome.' Lancet 365(9468): 1415-1428. El-Armouche, A., K. Wittkopper, et al. (2008). 'Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy.' Cardiovasc Res 80(3): 396-406. El Mesallamy, H. O., H. H. Ahmed, et al. (2012). 'Clinical significance of inflammatory and fibrogenic cytokines in diabetic nephropathy.' Clin Biochem 45(9): 646-650. Fellstrom, B. C., A. G. Jardine, et al. (2009). 'Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.' N Engl J Med 360(14): 1395-1407. Finkel, M. S., C. V. Oddis, et al. (1992). 'Negative inotropic effects of cytokines on the heart mediated by nitric oxide.' Science 257(5068): 387-389. Flett, A. S., M. P. Hayward, et al. (2010). 'Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans.' Circulation 122(2): 138-144. Foley, R. N., P. S. Parfrey, et al. (1998). 'Clinical epidemiology of cardiovascular disease in chronic renal disease.' Am J Kidney Dis 32(5 Suppl 3): S112-119. Fukuta, H. and W. C. Little (2008). 'Observational studies of statins in heart failure with preserved systolic function.' Heart Fail Clin 4(2): 209-216. Fukuta, H., D. C. Sane, et al. (2005). 'Statin therapy may be associated with lower mortality in patients with diastolic heart failure: a preliminary report.' Circulation 112(3): 357-363. Goette, A., T. Staack, et al. (2000). 'Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation.' J Am Coll Cardiol 35(6): 1669-1677. Gravning, J., S. Orn, et al. (2012). 'Myocardial connective tissue growth factor (CCN2/CTGF) attenuates left ventricular remodeling after myocardial infarction.' PLoS One 7(12): e52120. Gulick, T., M. K. Chung, et al. (1989). 'Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness.' Proc Natl Acad Sci U S A 86(17): 6753-6757. Halow, J. M., V. M. Figueredo, et al. (1999). 'Role of slowed Ca(2+) transient decline in slowed relaxation during myocardial ischemia.' J Mol Cell Cardiol 31(9): 1739-1748. Hanatani, A., M. Yoshiyama, et al. (1995). 'Inhibition by angiotensin II type 1 receptor antagonist of cardiac phenotypic modulation after myocardial infarction.' J Mol Cell Cardiol 27(9): 1905-1914. Hasenfuss, G., H. Reinecke, et al. (1994). 'Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium.' Circ Res 75(3): 434-442. Haugen, E., J. Chen, et al. (2007). 'Parallel gene expressions of IL-6 and BNP during cardiac hypertrophy complicated with diastolic dysfunction in spontaneously hypertensive rats.' Int J Cardiol 115(1): 24-28. He, H., F. J. Giordano, et al. (1997). 'Overexpression of the rat sarcoplasmic reticulum Ca2+ ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation.' J Clin Invest 100(2): 380-389. Hirota, H., K. Yoshida, et al. (1995). 'Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice.' Proc Natl Acad Sci U S A 92(11): 4862-4866. Hoekstra, T., J. M. Geleijnse, et al. (2005). 'Relationship of C-reactive protein with components of the metabolic syndrome in normal-weight and overweight elderly.' Nutr Metab Cardiovasc Dis 15(4): 270-278. Horton, J. W. (2004). 'Left ventricular contractile dysfunction as a complication of thermal injury.' Shock 22(6): 495-507. Huang, C. H., K. L. Chien, et al. (2007). 'Impact of heart failure and left ventricular function on long-term survival--report of a community-based cohort study in Taiwan.' Eur J Heart Fail 9(6-7): 587-593. Huang, Y., K. E. Walker, et al. (2004). 'Cardiac systolic and diastolic dysfunction after a cholesterol-rich diet.' Circulation 109(1): 97-102. Ihara, Y., K. Kageyama, et al. (2005). 'Overexpression of calreticulin sensitizes SERCA2a to oxidative stress.' Biochem Biophys Res Commun 329(4): 1343-1349. Ikonomidis, I., M. Nikolaou, et al. (2010). 'Association of left ventricular diastolic dysfunction with elevated NT-pro-BNP in general intensive care unit patients with preserved ejection fraction: a complementary role of tissue Doppler imaging parameters and NT-pro-BNP levels for adverse outcome.' Shock 33(2): 141-148. Ing, D. J., J. Zang, et al. (1999). 'Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x.' Circ Res 84(1): 21-33. Ivkovic, S., B. S. Yoon, et al. (2003). 'Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development.' Development 130(12): 2779-2791. Jeunemaitre, X., F. Soubrier, et al. (1992). 'Molecular basis of human hypertension: role of angiotensinogen.' Cell 71(1): 169-180. Ju, H., T. Scammel-La Fleur, et al. (1996). 'Altered mRNA abundance of calcium transport genes in cardiac myocytes induced by angiotensin II.' J Mol Cell Cardiol 28(5): 1119-1128. Kang, B. Y. and J. L. Mehta (2009). 'Rosuvastatin attenuates Ang II--mediated cardiomyocyte hypertrophy via inhibition of LOX-1.' J Cardiovasc Pharmacol Ther 14(4): 283-291. Kankaanpaa, M., H. R. Lehto, et al. (2006). 'Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels.' J Clin Endocrinol Metab 91(11): 4689-4695. Kao, Y. H., Y. C. Chen, et al. (2010). 'Tumor necrosis factor-alpha decreases sarcoplasmic reticulum Ca2+-ATPase expressions via the promoter methylation in cardiomyocytes.' Crit Care Med 38(1): 217-222. Kapadia, S. R., K. Yakoob, et al. (2000). 'Elevated circulating levels of serum tumor necrosis factor-alpha in patients with hemodynamically significant pressure and volume overload.' J Am Coll Cardiol 36(1): 208-212. Kawase, Y. and R. J. Hajjar (2008). 'The cardiac sarcoplasmic/endoplasmic reticulum calcium ATPase: a potent target for cardiovascular diseases.' Nat Clin Pract Cardiovasc Med 5(9): 554-565. Kemp, T. J., I. K. Aggeli, et al. (2004). 'Phenylephrine and endothelin-1 upregulate connective tissue growth factor in neonatal rat cardiac myocytes.' J Mol Cell Cardiol 37(2): 603-606. Kiewitz, R., C. Acklin, et al. (2003). 'Ca2+ -dependent interaction of S100A1 with the sarcoplasmic reticulum Ca2+ -ATPase2a and phospholamban in the human heart.' Biochem Biophys Res Commun 306(2): 550-557. Kim, J. A., M. Montagnani, et al. (2006). 'Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms.' Circulation 113(15): 1888-1904. Koitabashi, N., M. Arai, et al. (2007). 'Increased connective tissue growth factor relative to brain natriuretic peptide as a determinant of myocardial fibrosis.' Hypertension 49(5): 1120-1127. Koitabashi, N., M. Arai, et al. (2008). 'Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure.' Eur J Heart Fail 10(4): 373-379. Kosmala, W., R. Derzhko, et al. (2008). 'Plasma levels of TNF-alpha, IL-6, and IL-10 and their relationship with left ventricular diastolic function in patients with stable angina pectoris and preserved left ventricular systolic performance.' Coron Artery Dis 19(6): 375-382. Kranias, E. G. (1985). 'Regulation of calcium transport by protein phosphatase activity associated with cardiac sarcoplasmic reticulum.' J Biol Chem 260(20): 11006-11010. Krown, K. A., M. T. Page, et al. (1996). 'Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death.' J Clin Invest 98(12): 2854-2865. Kubota, T., G. S. Bounoutas, et al. (2000). 'Soluble tumor necrosis factor receptor abrogates myocardial inflammation but not hypertrophy in cytokine-induced cardiomyopathy.' Circulation 101(21): 2518-2525. Kumar, S., M. Raftery, et al. (2007). 'Anti-inflammatory effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors (statins) in peritoneal dialysis patients.' Perit Dial Int 27(3): 283-287. Lang, R. M., M. Bierig, et al. (2005). 'Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.' J Am Soc Echocardiogr 18(12): 1440-1463. Lee, J. J., S. Liu, et al. (2011). 'Myocardial T1 and extracellular volume fraction mapping at 3 tesla.' J Cardiovasc Magn Reson 13: 75. Lee, J. K., H. H. Lin, et al. (2011). 'Differential association of proinflammatory cytokines with left ventricular diastolic dysfunction in subjects with and without continuous ambulatory peritoneal dialysis.' Nutr Metab Cardiovasc Dis. Lester, S. J., A. J. Tajik, et al. (2008). 'Unlocking the mysteries of diastolic function: deciphering the Rosetta Stone 10 years later.' J Am Coll Cardiol 51(7): 679-689. Lin, C. Y., C. K. Wu, et al. (2012). 'Prognostic significance of left ventricular diastolic function in burn patients.' Shock 37(5): 457-462. Lin, L. Y., H. K. Kuo, et al. (2008). 'Confirming a biological pathway in the metabolic syndrome--insight from the NHANES 1999-2002.' Obesity (Silver Spring) 16(12): 2676-2681. Lipskaia, L., E. R. Chemaly, et al. (2010). 'Sarcoplasmic reticulum Ca(2+) ATPase as a therapeutic target for heart failure.' Expert Opin Biol Ther 10(1): 29-41. London, G. M. (2003). 'Cardiovascular disease in chronic renal failure: pathophysiologic aspects.' Semin Dial 16(2): 85-94. MacLennan, D. H., Y. Kimura, et al. (1998). 'Sites of regulatory interaction between calcium ATPases and phospholamban.' Ann N Y Acad Sci 853: 31-42. Makarenko, I., C. A. Opitz, et al. (2004). 'Passive stiffness changes caused by upregulation of compliant titin isoforms in human dilated cardiomyopathy hearts.' Circ Res 95(7): 708-716. Malavazos, A. E., G. Di Leo, et al. (2010). 'Relation of echocardiographic epicardial fat thickness and myocardial fat.' Am J Cardiol 105(12): 1831-1835. Mannheim, D., J. Herrmann, et al. (2011). 'Simvastatin preserves diastolic function in experimental hypercholesterolemia independently of its lipid lowering effect.' Atherosclerosis 216(2): 283-291. Mantuano, E., S. Santi, et al. (2007). 'Simvastatin and fluvastatin reduce interleukin-6 and interleukin-8 lipopolysaccharide (LPS) stimulated production by isolated human monocytes from chronic kidney disease patients.' Biomed Pharmacother 61(6): 360-365. Massie, B. M., P. E. Carson, et al. (2008). 'Irbesartan in patients with heart failure and preserved ejection fraction.' N Engl J Med 359(23): 2456-2467. Matthews, D. R., J. P. Hosker, et al. (1985). 'Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.' Diabetologia 28(7): 412-419. McCullough, P. A., E. F. Philbin, et al. (2002). 'Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study.' J Am Coll Cardiol 39(1): 60-69. Melendez, G. C., J. L. McLarty, et al. (2010). 'Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats.' Hypertension 56(2): 225-231. Miyamoto, M. I., G. A. Rose, et al. (1999). 'Abnormal global left ventricular relaxation occurs early during the development of pharmacologically induced ischemia.' J Am Soc Echocardiogr 12(2): 113-120. Miyazaki, Y., Y. Ikeda, et al. (2012). 'Heart failure-inducible gene therapy targeting protein phosphatase 1 prevents progressive left ventricular remodeling.' PLoS One 7(4): e35875. Morricone, L., A. E. Malavazos, et al. (2002). 'Echocardiographic abnormalities in normotensive obese patients: relationship with visceral fat.' Obes Res 10(6): 489-498. Nagueh, S. F., S. J. Stetson, et al. (2001). 'Decreased expression of tumor necrosis factor-alpha and regression of hypertrophy after nonsurgical septal reduction therapy for patients with hypertrophic obstructive cardiomyopathy.' Circulation 103(14): 1844-1850. Neagoe, C., M. Kulke, et al. (2002). 'Titin isoform switch in ischemic human heart disease.' Circulation 106(11): 1333-1341. Nesto, R. W. and G. J. Kowalchuk (1987). 'The ischemic cascade: temporal sequence of hemodynamic, electrocardiographic and symptomatic expressions of ischemia.' Am J Cardiol 59(7): 23C-30C. O'Riordain, M. G., D. S. O'Riordain, et al. (1996). 'Dosage and timing of anti-TNF-alpha antibody treatment determine its effect of resistance to sepsis after injury.' J Surg Res 64(1): 95-101. Ock, S., J. Ahn, et al. (2012). 'Receptor activator of nuclear factor-kappaB ligand is a novel inducer of myocardial inflammation.' Cardiovasc Res 94(1): 105-114. Ommen, S. R., R. A. Nishimura, et al. (2000). 'Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study.' Circulation 102(15): 1788-1794. Paraskevas, K. I. (2008). 'Statin therapy in peritoneal dialysis patients: effects beyond lipid lowering.' Int Urol Nephrol 40(1): 165-170. Paulus, W. J., C. Tschope, et al. (2007). 'How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology.' Eur Heart J 28(20): 2539-2550. Periasamy, M., T. D. Reed, et al. (1999). 'Impaired cardiac performance in heterozygous mice with a null mutation in the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 (SERCA2) gene.' J Biol Chem 274(4): 2556-2562. Prabhu, S. D. (2004). 'Cytokine-induced modulation of cardiac function.' Circ Res 95(12): 1140-1153. Priebe, L. and D. J. Beuckelmann (1998). 'Simulation study of cellular electric properties in heart failure.' Circ Res 82(11): 1206-1223. Qin, F., D. A. Siwik, et al. (2012). 'The polyphenols resveratrol and S17834 prevent the structural and functional sequelae of diet-induced metabolic heart disease in mice.' Circulation 125(14): 1757-1764, S1751-1756. Redfield, M. M., S. J. Jacobsen, et al. (2003). 'Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic.' JAMA 289(2): 194-202. Reich, H., J. A. Duncan, et al. (2003). 'Interactions between gender and the angiotensin type 1 receptor gene polymorphism.' Kidney Int 63(4): 1443-1449. Remppis, A., T. Greten, et al. (1996). 'Altered expression of the Ca(2+)-binding protein S100A1 in human cardiomyopathy.' Biochim Biophys Acta 1313(3): 253-257. Salemi, V. M., A. M. Bilate, et al. (2005). 'Reference values from M-mode and Doppler echocardiography for normal Syrian hamsters.' Eur J Echocardiogr 6(1): 41-46. Schiffrin, E. L., M. L. Lipman, et al. (2007). 'Chronic kidney disease: effects on the cardiovascular system.' Circulation 116(1): 85-97. Schultz Jel, J., B. J. Glascock, et al. (2004). 'Accelerated onset of heart failure in mice during pressure overload with chronically decreased SERCA2 calcium pump activity.' Am J Physiol Heart Circ Physiol 286(3): H1146-1153. Sciarretta, S., F. Paneni, et al. (2009). 'Role of the renin-angiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction.' Clin Sci (Lond) 116(6): 467-477. Seki, S., M. Nagai, et al. (2003). 'Impaired Ca2+ handling in perfused hypertrophic hearts from Dahl salt-sensitive rats.' Hypertens Res 26(8): 643-653. Shi-Wen, X., A. Leask, et al. (2008). 'Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis.' Cytokine Growth Factor Rev 19(2): 133-144. Shiraki, A., J. Oyama, et al. (2012). 'The glucagon-like peptide 1 analog liraglutide reduces TNF-alpha-induced oxidative stress and inflammation in endothelial cells.' Atherosclerosis 221(2): 375-382. Spinale, F. G., M. L. Coker, et al. (2000). 'A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure.' Circulation 102(16): 1944-1949. Stenvinkel, P., E. Rodriguez-Ayala, et al. (2006). 'Statin treatment and diabetes affect myeloperoxidase activity in maintenance hemodialysis patients.' Clin J Am Soc Nephrol 1(2): 281-287. Takahashi, N., H. Murakami, et al. (2000). 'Association of a polymorphism at the 5'-region of the angiotensin II type 1 receptor with hypertension.' Ann Hum Genet 64(Pt 3): 197-205. Tang, Y., X. Tian, et al. (2012). 'Abnormal termination of Ca2+ release is a common defect of RyR2 mutations associated with cardiomyopathies.' Circ Res 110(7): 968-977. Terashita, Z., M. Kawamura, et al. (1992). 'Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.' J Pharmacol Exp Ther 260(2): 748-755. Tong, Z., R. Chen, et al. (2009). 'Susceptibility to liver fibrosis in mice expressing a connective tissue growth factor transgene in hepatocytes.' Hepatology 50(3): 939-947. Tsai, C. T., D. L. Wang, et al. (2007). 'Angiotensin II increases expression of alpha1C subunit of L-type calcium channel through a reactive oxygen species and cAMP response element-binding protein-dependent pathway in HL-1 myocytes.' Circ Res 100(10): 1476-1485. van der Meer, R. W., L. J. Rijzewijk, et al. (2008). 'The ageing male heart: myocardial triglyceride content as independent predictor of diastolic function.' Eur Heart J 29(12): 1516-1522. van Heerebeek, L., A. Borbely, et al. (2006). 'Myocardial structure and function differ in systolic and diastolic heart failure.' Circulation 113(16): 1966-1973. van Kimmenade, R. R., J. L. Januzzi, Jr., et al. (2006). 'Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure.' J Am Coll Cardiol 48(6): 1217-1224. Ver Heyen, M., S. Heymans, et al. (2001). 'Replacement of the muscle-specific sarcoplasmic reticulum Ca(2+)-ATPase isoform SERCA2a by the nonmuscle SERCA2b homologue causes mild concentric hypertrophy and impairs contraction-relaxation of the heart.' Circ Res 89(9): 838-846. Vetter, R., U. Rehfeld, et al. (2002). 'Transgenic overexpression of the sarcoplasmic reticulum Ca2+ATPase improves reticular Ca2+ handling in normal and diabetic rat hearts.' FASEB J 16(12): 1657-1659. Villegas, S., F. J. Villarreal, et al. (2000). 'Leukemia Inhibitory Factor and Interleukin-6 downregulate sarcoplasmic reticulum Ca2+ ATPase (SERCA2) in cardiac myocytes.' Basic Res Cardiol 95(1): 47-54. Wanner, C., V. Krane, et al. (2005). 'Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.' N Engl J Med 353(3): 238-248. Weber, K. T., C. G. Brilla, et al. (1993). 'Myocardial fibrosis: functional significance and regulatory factors.' Cardiovasc Res 27(3): 341-348. Wong, C. Y., T. O'Moore-Sullivan, et al. (2004). 'Alterations of left ventricular myocardial characteristics associated with obesity.' Circulation 110(19): 3081-3087. Wu, C. K., J. K. Lee, et al. (2011). 'Plasma levels of tumor necrosis factor-alpha and interleukin-6 are associated with diastolic heart failure through downregulation of sarcoplasmic reticulum Ca2+ ATPase.' Crit Care Med 39(5): 984-992. Wu, C. K., J. L. Luo, et al. (2010). 'Demonstrating the pharmacogenetic effects of angiotensin-converting enzyme inhibitors on long-term prognosis of diastolic heart failure.' Pharmacogenomics J 10(1): 46-53. Wu, C. K., C. Y. Yang, et al. (2012). 'The relationship among central obesity, systemic inflammation, and left ventricular diastolic dysfunction as determined by structural equation modeling.' Obesity (Silver Spring) 20(4): 730-737. Xu, T., T. Wang, et al. (1992). 'Centrally acting endogenous hypotensive substances in rats subjected to endotoxic shock.' Life Sci 51(23): 1817-1821. Yamada, M., Y. Ikeda, et al. (2006). 'Inhibition of protein phosphatase 1 by inhibitor-2 gene delivery ameliorates heart failure progression in genetic cardiomyopathy.' FASEB J 20(8): 1197-1199. Yang, R. Y., G. A. Rabinovich, et al. (2008). 'Galectins: structure, function and therapeutic potential.' Expert Rev Mol Med 10: e17. Zhang, J., Y. Xu, et al. (2010). 'Effect of simvastatin on collagen I deposition in non-infarcted myocardium: role of NF-kappaB and osteopontin.' Can J Physiol Pharmacol 88(11): 1026-1034. Zhang, Y., A. J. Edgley, et al. (2012). 'FT011, a new anti-fibrotic drug, attenuates fibrosis and chronic heart failure in experimental diabetic cardiomyopathy.' Eur J Heart Fail 14(5): 549-562. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/6001 | - |
dc.description.abstract | 本研究的目的,主要在於發炎反應物質(proinflammatory cytokines)和左心室舒張功能不良(left ventricular diastolic dysfunction)發生的可能分子機轉。首先研究血漿中的蛋白質對於舒張性心衰竭發生機制的影響,過去的研究顯示SERCA2(sarcoplasmic reticulum Ca2+ ATPase)是影響舒張性心衰竭生成最重要的鈣離子通道,過去的研究也顯示SERCA2的功能跟質量都明顯的影響舒張性心衰竭的發生率。我們的初步研究顯示,血漿中的angiotensin II對於SERCA2促進子(promoter)的影響程度不及tissue necrosis factor (TNF-α)或者interleukin-6 (IL-6)等前發炎反應物質,因此以心肌細胞模式研究TNF-α或者IL-6影響SERCA2表現的訊息傳導模式。我們使用HL-1心肌細胞,複製促進子前1754苷基片段,藉由質體導入HL-1心肌細胞中,接著分別研究TNF-α或者IL-6對於促進子的影響,直接刺激HL-1細胞對於mRNA,蛋白質總量的改變。結果發現TNF-α或者IL-6可以抑制SERCA2促進子的活性乃至於mRNA,蛋白質的量,甚至改變鈣離子通道回收鈣離子的能力(鈣離子電流坡度變得平緩)。接著研究影響SERCA2最強的激素- TNF-α可能抑制SERCA2的機制,同樣使用HL-1細胞,加入TNF-α後研究下游可能的機轉,結果首次發現,TNF-α藉由Nuclear Factor-KappaB (NF-κB) 反應單元結合蛋白機轉抑制SERCA2基因的表現,同時進一步抑制左心室的舒張功能。我們同時也在動物模式中驗證上述細胞模式所發現的機轉,以lipopolysaccharide(LPS)刺激大鼠,引發血漿中的TNF-α上升後上升後,同樣會經由上述的機轉使得大鼠的左心室舒張功能變差,但使用NF-κB抑制劑-PDTC或者simvastatin來抑制發炎反應卻可以在細胞模式中使得此機轉阻斷,SERCA2的量回升。同樣在動物模式下,利用口服的simvastatin給予大鼠服用,抑制血漿中的TNF-α上升,對比對照組的老鼠發現,經由抑制NF-κB反應單元結合蛋白機轉不僅使得SERCA2的量回升,也同樣可以改善左心室的舒張功能不良。
臨床的研究上,也研究血漿中的前發炎反應物質如TNF-α或者IL-6上升和左心室舒張功能各項指標的相關性。首先,我們研究血漿中的TNF-α或者IL-6和心臟超音波下各項標準的評估左心室舒張功能的指標。第一個研究的群體是單純舒張性心衰竭的病患,第二個群組則引入30位加護病房的病患同時具有左心室舒張功能不全者。我們發現在單純舒張性心衰竭病患血漿中的TNF-α或者IL-6和超音波下的左心室舒張功能指標有顯著的相關性(各項指標P<0.01),同時在嚴重的病患血漿中的發炎反應指數上升,左心室舒張功能也明顯地變差,當病患狀況改善時,發炎指數和左心室舒張功能也平行的發生改善。接著引入了極端發炎反應的病患也就是56位嚴重燒傷的病患,在這樣的族群當中,發現不僅發炎指數更顯著地和左心室舒張功能的超音波指標明顯的相關,同時經過迴歸分析校正之後,左心室舒張功能在這樣的病患更是影響預後的一項獨立因子(HR = 3.99, p = 0.038)。 以上為住院病患具有高發炎反應的患者,為了評估一般族群中前發炎反應是否與左心室舒張功能不全的發生有關,我們選擇臨床門診比較常見,血漿中可能前發炎反應會較正常人高的族群,第一個族群選取了102位肥胖的族群,血漿中的發炎指數顯著的上升,同時以斷層掃描定義內臟脂肪(visceral fat)的多寡,以心臟超音波評估病患是否有左心室舒張功能不全。使用結構方程分析後發現,內臟脂肪主要可以透過發炎反應的產生來導致左心室舒張功能不全的發生,而不是因為脂肪滲透引起心臟功能不全的發生。另外一個族群則選取腹膜透析的病患,我們比較發炎反應,腹膜透析,左心室舒張功能不全三者之間的關係,發現發炎反應本身是和左心室舒張功能不全發生一項獨立的因子,腹膜透析也是和左心室舒張功能不良發生一項顯著的相關因素,同時兩者有交互作用存在,此交互作用可以額外的增加舒張性心臟功能不良發生的機會。最後,我們也研究新的血漿中和組織纖維化相關的激素conntective tissue growth factor (CTGF),我們利用臨床上台灣舒張性心衰竭群體資料,左心室肥厚的狗模式,心肌細胞模式三種不同的模式來分析,第一次發現血漿中的CTGF和嚴重舒張性心衰竭的心臟超音波E/E’有明顯的相關性存在,另外以核磁共振(MRI)評估左心室的舒張功能也發現,心臟纖維化的程度也和血漿中的CTGF明顯的相關,在動物模式上,組織的CTGF和心臟纖維化的程度經過兩週後平行的上升了,同時CTGF的濃度和血壓的變動有顯著的相關性存在,更是回歸分析後影響心臟舒張功能不良發生的獨立因素。 總結而言,本研究利用動物、細胞模式及基礎分生研究來證實前發炎反應物質(TNF-α)和舒張性心衰竭發生的可能分子機轉,進而發現simvastatin可以阻斷TNF-α訊息傳遞,有治療舒張性心衰竭的效果,再不同程度的發炎反應病患身上驗證了 TNF-α等前發炎反應物質和左心室舒張功能指標的相關程度,並推論出內臟脂肪,腹膜透析都可以透過發炎反應或者交互作用引起左心室的舒張功能不全發生,另外也驗證了新的纖維化指標CTGF可以作為預估左心室舒張功能不全,或者新的治療方法的依據。 | zh_TW |
dc.description.abstract | The aim of the present doctoral thesis is to investigate the molecular mechanism by which proinflammatory cytokines are involved in the pathegenesis of diastolic heart failure (DHF). We try to find the mechanism by which inflammatory cytokines influence cardiac diastolic function. We realized that the sarcoplasmic reticulum Ca2+ ATPase (SERCA) is essential to the regulation of intracellular calcium levels in cardiac and is crutial for the development of DHF. Our pilot study reveal that Angiotensin II does not appear to exert an effect on SERCA2 levels in cardiomyocytes, but pro-inflammatory cytokines such as tissue necrosis factor-alpha (TNF-α) or IL-6 have even greater effect over SERCA2 expression in cardiomyocyte models. Regarding TNF-α or IL-6 and SERCA2 signal transduction, we investigated whether TNF-α or IL-6 modulates SERCA2 calcium current through transcriptional regulation, using a HL-1 cells model. We cloned a 1754 bp promoter fragment of rat SERCA2 gene and amplified by polymerase chain reaction (PCR). We determined that TNF-α or IL-6 decreased SERCA2 mRNA, protein levels and SERCA2 promoter activities, which resulted in an attenuation calcium transient. Accordingly, in the following study, we explored the pathway of TNF-α on the transcriptional regulation of SERCA2 cardiomyocytes. We first found that TNF-α decreased SERCA2 gene expression and induced left ventricular (LV) diastolic dysfunction through Nuclear Factor-KappaB (NF-κB) Element–Binding Protein–Dependent Pathway. We also used an in vivo rat model of hyper-TNF-α to verify the results obtained in the cellular study. The upstream NF-κB dependent pathway was critical for TNF-α–induced decreased transcription of SERCA2 gene. The NF-κB blocker (PDTC) and pre-incubation of simvastatin inhibited TNF-α–induced NF-κB dependent pathway and augmented expression of SERCA2 gene which in turns lead to improvement of LV diastolic function in a in-vivo rat model of LPS injection.
Regarding clinical studies, to evaluate the association between cytokines (TNF-αor IL-6) and left ventricular dysfunction indices, first, we sought to assess plasma levels of IL-6 and TNF-α in patients with DHF, including critically ill patients. We included several goups of patients. The first group consisted of pure DHF patients, and the second group enrolled 30 consecutive patients with left ventricular diastolic dysfuction that were admitted to the intensive care units (ICUs). Significant correlations (p < .01 for each) were found for TNF-α, IL-6 and cardiac diastolic dysfunction indices. Cytokine levels were also correlated with diastolic function in critical ill patients, and diastolic function improved significantly in association with decrease of cytokines. We later included 56 critically burned patients and we found that there was a significant correlation between LV diastolic dysfunction and in-hospital mortality in critically burned patients (HR = 3.99, p = 0.038) after risk factors adjusted. Regarding the patients in the general population with higher inflammatory status, we further included 2 other goups of patients to prove the above hypothesis. First we we included 102 obese adults. In this study, we found a significant association between LV diastolic dysfunction and fat content as measured by CT. With the analysis, we verified that fat deposition acts mainly through inflammation to affect LV diastolic dysfunction and less by its own effect (e.g. fat infiltration of LV). We also tried to establish the association between inflammation and LV diastolic dysfunction in peritoneal dialysis (PD) and non-PD patients. We established that an interaction between PD and inflammation, especially TNF-α, was also shown to further aggravate LV diastolic dysfunction. Finally, we investigated an emerging marker for tissue fibrosis, connective tissue growth factor (CTGF) and its association with cardiac diastolic function using cellular and animal models and clinical human data. Significant correlation was found between plasma CTGF and E/e’in DHF patients. Severity of cardiac fibrosis evaluated by CMRI also correlated with CTGF. In the cell model, stretch increased secretion of CTGF from cardiomyocytes. In the canine model, myocardial tissue CTGF expression and fibrosis significantly increased after 2 weeks of aortic banding. In conclusions, the present doctoral thesis combined animal, cell models and molecular studies to demonstrate how cytokines (including TNF-α, IL-6 and CTGF) are involved in the pathogeneses of cardiac fibrosis, SERCA2 regulation, which are important substrates of DHF. Current study also discovered that simvastatin could block TNF-αsignal transduction which could be beneficial for the treatment of DHF. By testing the association of TNF-α and LV diastolic dysfunction parameters in patients with different severities of DHF, we could conclude that both visceral fat, PD could interact with inflammation, which in turns, lead to the development of LV diastolic dysfunction. Finally, we provided evidence that CTGF could be a marker for LV diastolic dysfunction and also targets of treatment. | en |
dc.description.provenance | Made available in DSpace on 2021-05-16T16:19:16Z (GMT). No. of bitstreams: 1 ntu-102-D98421008-1.pdf: 3121015 bytes, checksum: f411866613c2a48594b67d3fd86b8429 (MD5) Previous issue date: 2013 | en |
dc.description.tableofcontents | 目錄…………………………………………………………..…………………………..i
圖目錄……………………………………………….………………………………….iv 表目錄…………………………………………………………………………………vi 中文摘要……………………………………………………………………………...viii Abstract………………………………………………………………………….…...xi 縮寫對照表……………………………………………………………………………xiv 第一章 緒論……….……………………………………………………………..1 第一節 心衰竭的重要性....................………….…………………………………1 第二節 正常收縮功能心衰竭與左心室舒張功能不全….……...…………….1 第三節 鈣離子通道在心臟舒張功能不良的角色……..…....………………….. 8 第四節 臨床族群中和HFpEF或左心室舒張功能相關的biomarkers……….12 第五節 研究目的與假說………………...………………………..…….....…...17 第二章 研究方法及材料……………………………………………………….........19 第一節 TNF-α及IL-6可能透過transcription level的抑制,影響SERCA2的 表現……………………………………...………..……………………..19 第二節 探討TNF-α可能影響SERCA2的機轉(pathway),是否直接影響心臟 舒張功能以及是否可以被藥物所反轉-細胞及動物實驗模式………..21 第三節 探討臨床DHF病患,加護病房嚴重發炎反應的病患,發炎反應物質 與心臟舒張功能的關係以及預後的影響……………..……....……….24 第四節 一般族群中subclinical inflammation是否會影響左心室舒張功能的產 生,可能的機轉如何?.......................................................……….……….28 第五節 新的左心室纖維化標的- CTGF和DHF的相關性以及可能影響機轉.31 第三章 研究結果……….……………………………………………………...…….34 第一節 TNF-α及IL-6可能透過transcription level的抑制,影響SERCA2 現……….………………………………...………..……………………….34 第二節 探討TNF-α可能影響SERCA2的機轉(pathway),是否直接影響心臟 舒張功能以及是否可以被藥物所反轉-細胞及動物實驗模式………..35 第三節 探討臨床DHF病患,加護病房嚴重發炎反應的病患,發炎反應物質 與心臟舒張功能的關係以及預後的影響………………....…………...37 第四節 一般族群中subclinical inflammation是否會影響左心室舒張功能的產 生,可能的機轉如何?...............................................................…..……..39 第五節 新的左心室纖維化標的- CTGF和DHF的相關性以及可能影響機 轉………………………………………………………………………...41 第四章 討論……….…………………………………………………………………44 第一節 TNF-α及IL-6可能透過transcription level的抑制,影響SERCA2 現……….………………………………...………..……………………….44 第二節 探討TNF-α可能影響SERCA2的機轉(pathway),是否直接影響心臟 舒張功能以及是否可以被藥物所反轉-細胞及動物實驗模式………..46 第三節 探討臨床DHF病患,加護病房嚴重發炎反應的病患,發炎反應物質 與心臟舒張功能的關係以及預後的影響………………....…………...49 第四節 一般族群中subclinical inflammation是否會影響左心室舒張功能的產 生,可能的機轉如何?...............................................................…..……..52 第五節 新的左心室纖維化標的- CTGF和DHF的相關性以及可能影響機 轉………………………………………………………………………...57 第五章 結論及展望…….……………………………………………………………61 第六章 論文英文簡述….……………………………………………………………66 第七章 參考文獻..….………………………………………………………………74 第八章 圖表……….…………………………………………………………………85 第九章 附錄……….………………………………………………………………133 圖 目 錄 圖2-1如何量測二尖瓣流入血流,E波以及A波…………………………….……....85 圖2-2診斷舒張性心衰竭的流程圖(2007年歐洲心臟科學會共識)………….….....86 圖2-3預設體脂肪影響左心室舒張功能的結構方程模式圖..…………………….…87 圖2-4如何由心臟核磁共振造影T1量測細胞外體積…...………………..…………88 圖3-1 TNF-α及IL-6在HL-1心肌細胞上,以轉錄調控的方式來減少SERCA2基 因的表現,影響促進子,mRNA,乃至於蛋白質濃度的整體表現………..….89 圖3-2 HL-1心肌細胞中的TNF-α及IL-6對SERCA2鈣離子通道電流的影響……90 圖3-3重症病患血清(PAT)相較於對照組(CTL)血清作用在HL-1心肌細胞上,對於 SERCA2蛋白質濃度以及mRNA量的影響….……………..…………..……91 圖3-4 心肌細胞的TNF-α經由SERCA2基因啟動子區域中的NF-κB反應單元區來 調控SERCA2鈣離子通道的表現…..…………………………………...……92 圖3-5 TNF-α誘導的訊息傳遞子及轉錄活化子…………………………………...…93 圖3-6 TNF-α誘導的訊息傳遞子及轉錄活化子,經由NF-κB反應單元活化下游的 反應路徑,導致NF-κB p65次單元體轉化入細胞核中………..………..……94 圖3-7 TNF-α對HL-1心肌細胞中SERCA2鈣離子通道表現的影響受到NF-κB蛋 白抑制劑PDTC所阻斷………..………….…………………...………...……95 圖3-8 TNF-α對HL-1心肌細胞中SERCA2鈣離子通道表現的影響受到已知的 TNF-α抑制劑,simvastatin所阻斷…………………………...………..……96 圖3-9 TNF-α經由NF-κB反應單元抑制SERCA2表現的路徑在動物實驗中因使用 simvastatin所阻斷………………………….......................…………….…97 圖3-10血漿中的TNF-α上升影響心臟的舒張功能路徑,在動物實驗中因使用 simvastatin所阻斷…………………………………...............................…98 圖3-11整體模式圖顯示TNF-α抑制SERCA2表現同時導致心臟舒張功能不良的訊 息傳導方式..……………………………………….............……………99 圖3-12以純粹舒張性心衰竭病患為例,血漿中的TNF-α及IL-6和心臟超音波下, 各項心臟舒張功能指標的相關性..………….......................……………100 圖3-13以嚴重燒傷病患為例,血漿中的TNF-α及IL-6和心臟超音波下,各項心臟 舒張功能指標,以及燒傷面積的相關性..….......................……………101 圖3-14在嚴重燒傷的群體上,根據左心室舒張功能Kaplan-Meier圖………….....102 圖3-15以結構方程分析得到的機轉路徑模式圖..………..….………..……..…103 圖3-16 在舒張性心衰竭病患上,血漿中connetive tissue growth factor(CTGF)和心 臟超音波下,各項心臟舒張功能指標的相關性...........................……104 圖3-17心臟核磁共振造影下的細胞外體積(ECV)和血漿中的connetive tissue growth factor(CTGF)相關性..…………………………….........................……105 圖3-18舒張性心衰竭的動物模式與正常動物血行動力以及超音波型態的差異...106 圖3-19組織中CTGF和心臟舒張功能的相關性..……………………………...…107 圖3-20拉力刺激心肌細胞後,觀察釋放到培養液中的CTGF濃度....………..…108 表 目 錄 表一 群體一中實驗組與對照組之間的基本資料,超音波型態與血清中的 激素濃度………………..…………...........................................................109 表二 群體二加護病房嚴重病患的基本資料與血漿中激素濃度………………….111 表三 群體三燒傷病患的基本資料以及血漿中的激素濃度……………………….113 表四 在群體二嚴重疾病病患轉入轉出加護病房前後的血漿中Interleukin-6, tissue necrosis factor-alpha, 以及心臟超音波變化………………………………115 表五 群體三燒傷病患轉出轉入加護病房前後的血漿中Interleukin-6, tissue necrosis factor-alpha, 以及心臟超音波舒張功能指標………………………………116 表六 以Cox regression 模式分析影響燒傷病患住院死亡率的因素…………117 表七 群體一中實驗組與對照組的基本資料與心臟超音波資料………………118 表八 群體二正常腎臟功能與腹膜透析病患的基本資料,心臟超音波資料與血漿中 的激素濃度 ………………….………………………………………………120 表九 Pearson bivariate 相關分析脂肪組織與臨床資料的相關性……………122 表十 多變項迴歸分析決定和左心室舒張功能不良發生的相關因子…………123 表十一 根據結構方程做路徑分析………………………………………………125 表十二 多變項迴歸分析決定腹膜透析病患和左心室舒張功能不良發生的 相關因子…………………………………………………………………...126 表十三 將舒張性心衰竭(DHF)病患依照舒張功能的嚴重程度分組,條列DHF病患 以及對照組基本資料,血漿中的CTGF濃度………………………………127 表十四 線性多變項分析在舒張性心衰竭病患中影響心臟超音波E/e'數值的因素………………………129 表十五 主動脈狹窄手術與對照組的狗在手術前後(兩個禮拜)的基本資料,血行動 力變化,心臟超音波資料………………………………………………… 130 表十六 線性多變項分析在動物模式中影響心臟超音波E/e'數值的因素………132 | |
dc.language.iso | zh-TW | |
dc.title | 左心室舒張功能不全之分子及臨床研究 | zh_TW |
dc.title | Molecular Mechanisms and Clinical Studies of Left Ventricular Diastolic Dysfunction | en |
dc.type | Thesis | |
dc.date.schoolyear | 102-1 | |
dc.description.degree | 博士 | |
dc.contributor.oralexamcommittee | 楊偉勛,林幸榮,徐國基 | |
dc.subject.keyword | 左心室舒張功能,發炎反應,心衰竭,分子機轉,臨床研究, | zh_TW |
dc.subject.keyword | Left ventricular diastolic function,inflammation,heart failure,molecular mechanism,clinical studies, | en |
dc.relation.page | 133 | |
dc.rights.note | 同意授權(全球公開) | |
dc.date.accepted | 2013-11-26 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 臨床醫學研究所 | zh_TW |
顯示於系所單位: | 臨床醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-102-1.pdf | 3.05 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。